Background Image

Alisa G. Woods

In this Section
Alisa G. Woods

Research Assistant Professor
Laboratory for Proteomics and Biochemistry
Chemistry & Biomolecular Science
147 Science Center
Clarkson University
PO Box 5810
Potsdam, NY 13699-5810

Phone: 315-268-7763

Educational Background
2012 MS, Mental Health Counseling, University of Massachusetts, Boston
1998 Ph.D., Psychobiology, University of California, Irvine
1992 BS, Psychology, SUNY Plattsburgh, NY, Magna Cum Laude

Professional Experience
2013-present    Counselor and Neuropsychology Researcher, Neuropsychology Clinic
                       and Psychoeducation Services, SUNY Plattsburgh, NY
2011-2012        Intern, SUNY Potsdam Mental Health Counseling Center
2011                Visiting Assistant Professor, Biology, Clarkson University
2004-present    Director, Padure Biomedical Consulting
2010                Visiting Assistant Professor, Psychology, SUNY Plattsburgh, NY
2006                Adjunct Professor, Psychology, Iona College, NY
2000-2004        Scientific Director, SandlerScience, IntraMed Educational Group
                       and Medicus NY
1998-2000        Visiting Scientist, University of Freiburg and 
                       the Alexander von Humboldt Foundation, Freiburg, Germany

Research Interests
The long term goal of my research is to understand the connections between biochemistry and behavior in neurodevelopmental disorders, including autism and ADHD. I have published sixteen papers in the last two years focusing on proteomic methodology and/or behavioral disorders. I am particularly interested in the identification of protein biomarkers for diagnosis and prognosis of neurodevelopmental disorders and in their use for monitoring the psychotherapeutic/behavioral treatment of neurodevelopmental disorders.

Selected Publications
Wormwood, K., Ryan, J.P., Russell, S., Darie, C.C., Woods, A.G. (2013) The potential for proteomics in understanding neurodevelopmental disorders. (In preparation).
Woods, A.G., Mahdavi, E., Ryan, J.P. (2013) Treating clients with Asperger's syndrome. (In preparation).

Woods, A.G., Sokolowska, I., Deinhardt, K., Sandu, C., Darie, C.C. (2013) Identification of tumor differentiation factor (TDF) in select CNS neurons. Brain Struct. Funct. May 17. (EPub ahead of print).

Ngounou Wetie A.G., Sokolowska I., Woods A.G., Roy U., Deinhardt K., Darie C.C. (2013) Protein-protein interactions: switch from classical methods to proteomics and bioinformatics-based approaches. Cell. Mol. Life Sci. Apr 12. (Epub ahead of print).

Sokolowska I., Ngounou Wetie A.G., Roy U, Woods A.G., Darie C.C. (2013) Mass spectrometry investigation of glycosylation on tche NXS/T sites in recombinant glycoproteins. Biochim Biophys Acta. doi:pii: S1570-9639(13)00176-3. 10.1016/j.bbapap.2013.04.022.(Epub ahead of print).

Ngounou Wetie, A.G., Sokolowska I., Woods, A.G., Roy, U., Loo, J.A., Darie, C.C. (2013) Investigation of stable and transient protein-protein interactions: past, present and future. Proteomics. 13: 538–557. doi: 10.1002/pmic.201200328.

Roy U., Sokolowska I., Woods A.G., Darie C.C. (2012) Structural investigation of tumor differentiation factor. Biotechnol Appl Biochem. 59(6):445-50. doi: 10.1002/bab.1046. Epub 2012 Nov 20.

Ngounou Wetie, A.G., Sokolowska, I., Wormwood, K., Ryan, J.P., Belinger, K., Michel, T.M., Thome, J., Darie, C.C., Woods, A.G. (2013) Mass spectrometry for the detection of potential psychiatric biomarkers. J. Mol. Psychiatry. In Press. 

Woods, A.G., Ngounou Wetie, A.G., Sokolowska, I., Russell, S., Ryan, J.P., Michel, T.M., Thome, J., Darie, C.C. (2012) Mass spectrometry as a tool for studying autism spectrum disorder. J. Mol. Psychiatry. In Press.

Shaw, M., Hodgkins, P., Caci, H., Young, S., Kahle, J., Woods, A.G., Arnold, L.E. (2012) A systematic review and analysis of long-term outcomes in attention-deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med. 4:10:99.

Ngounou Wetie, A.G., Sokolowska, I., Woods, A.G., Wormwood, K.L., Dao, S., Patel, S., Clarkson, B.D., Darie, C.C. (2012) Automated mass spectrometry-based functional assay for the routine analysis of the secretome. J. Lab. Autom. EPub Ahead of Print.

Sokolowska, I., Woods, A.G., Gawinowicz, M.A., Roy, U., Darie, C.C. (2012). Identification of a potential tumor differentiation factor (TDF) receptor candidate in prostate cancer cells. FEBS Journal, 279: 2579-2594. DOI: 10.1111/j.1742-4658.2012.08641.x

Woods, A.G., Sokolowska, I., Darie, C.C.(2012). Identification of consistent alkylation of cysteine-less peptides in a proteomics experiment. Biochemical and Biophysical Research Communications, 419 (2): 305-8.

Sokolowska, I., Woods, A.G., Gawinowicz, M.A., Roy, U., Darie, C.C.(2012). Identification of a potential tumor differentiation factor (TDF) receptor from steroid-responsive and steroid-resistant breast cancer cells., J. Biol. Chem., 287(3):1719-33.

Woods A.G., Sokolowska I., Taurines R., Gerlach M., Dudley E., Thome J., Darie C.C. (2012). Potential biomarkers in psychiatry: focus on the cholesterol system. doi: 10.1111/j.1582-4934.2012.01543.

Shaw M,. Caci C., Hodgkins P., Kahle J., Callamaras N., Woods A. (2011) Review of studies of ADHD: long-term outcomes with and without treatment. Eur. Psychiatry; 26(211):579.

Shaw M., Caci C., Hodgkins P., Kahle J., Callamaras N., Woods A. (2011) Long-term outcomes of ADHD: Global and regional study publication trends. Eur. Psychiatry; 26(211):578.

Hodgkins, P., Arnold, L.E., Shaw, M., Caci, H., Kahle, J., Woods, A.G., Young, S. (2011). A systematic review of long-term outcomes in ADHD: global publication trends. Front. Psychiatry. 2:84. doi: 10.3389/fpsyt.2011.00084.

Thome J., Coogan A.N., Woods A.G., Darie C.C., Häßler F. (2011). CLOCK Genes and Circadian Rhythmicity in Alzheimer Disease. J Aging Res., 2011:383091 doi:10.4061/2011/383091.

Sokolowska, I., Woods, A.G., Wagner, J., Dorler, J., Wormwood, K., Thome, J., Darie, C.C. (2011). Mass spectrometry for proteomics-based investigation of oxidative stress and heat shock proteins. ACS Books, Oxidative Stress: Diagnostics and Therapy. Editors: E. Silvana Andreescu & Maria Hepel;1083 (12), 341-367.

Woods, A.G., Sokolowska, I., Yakubu, R., Butkiewicz, M., LaFleur, M., Talbot, C., Darie, C.C. (2011). Blue Native PAGE and mass spectrometry as an approach for the investigation of stable and transient protein-protein interactions. ACS Books, Oxidative Stress: Diagnostics and Therapy. Editors: E. Silvana Andreescu & Maria Hepel;1083 (13), 369-411.

Bizon, J.L., Woods, A.G. (2009) Animal Models of Human Cognitive Aging. 1st Ed. Springer, Humana Press, New York, NY. ISBN 978-1-58829-996-3.

To S.E., Zepf R.A., Woods A.G. (2005). The symptoms, neurobiology, and current pharmacological treatment of depression. J. Neurosci. Nurs. 37: 102-107.

Phinney A.L., Calhoun M.E., Woods A.G., Deller T., Jucker M. (2004). Stereological analysis of the reorganization of the dentate gyrus following entorhinal cortex lesion in mice. Eur. J. Neurosci. 19: 1731-1720.

Del Turco D., Woods A.G., Gebhardt C., Phinney A.L., Jucker M., Frotecher M., Deller T. (2003). Comparison of commissural sprouting in the mouse and rat fascia dentata after entorhinal cortex lesion. Hippocampus. 13: 685-699.

Dallner C., Woods A.G., Deller T., Kirsch M., Hofmann H.D. (2002). CNTF and CNTF receptor alpha are constitutively expressed by astrocytes in the mouse brain. Glia. 37: 374-378.

Woods A.G., Poulsen F.R., Gall C.M. (1999). Dexamethasone selectively suppresses microglial trophic responses to hippocampal deafferentation. Neuroscience. 91:1277-1289.

Woods A.G., Guthrie K.M., Kurlawalla M.A., Gall C.M. (1998). Deafferentation-induced increases in hippocampal insulin-like growth factor-1 messenger RNA expression are severely attenuated in middle aged and aged rats. Neuroscience. 83:663-668.

Guthrie K.M., Woods A.G., Nguyen T., Gall C.M. (1997). Astroglial ciliary neurotrophic factor mRNA expression is increased in fields of axonal sprouting in deafferented hippocampus. J. Comp. Neurol. 386:137-148.

Woods A.G., Cribbs D.H., Whittemore E.R., Cotman C.W. (1995). Heparan sulfate and chondroitin sulfate glycosaminoglycan attenuate beta-amyloid(25-35) induced neurodegeneration in cultured hippocampal neurons. Brain Res. 697:53-62.